Health & Food
Qsymia weight-loss drug approved by FDA
WASHINGTON (KABC) -- A new prescription drug to fight obesity has been approved by the Food and Drug Administration.
The pill, called Qsymia, is designed for those who are overweight and have at least one weight-related condition, such as high blood pressure or diabetes. It is expected to help them lose 10 percent of their weight, in combination with diet and exercise.
The drug was previously known as Qnexa. The FDA rejected it two years ago because of fears over increased heart rate and birth defects.
It was approved after the manufacturer began a risk management program, controlling its use.
Qsymia is a combination of two FDA-approved drugs, phentermine and topiramate, which have been known to help with weight loss. Phentermine is indicated for short-term weight loss in overweight or obese adults who are exercising and eating a reduced-calorie diet. Topiramate is an anticonvulsant that makes people feel more satisfied after eating.
The drug's maker, Vivus Inc., said it plans to bring the drug to market in the fourth quarter of this year. It hasn't yet decided what the pills will cost.
The Associated Press contributed to this report.
health, health care, obesity, fda, health & food
- MTA bus drivers claim illness from pesticide 31 min ago
- Prostitution bust at OC hotel - exclusive 3 min ago
- LA plastic-bag ban tentatively approved
- NSA foiled 50+ terrorist plots - director
- Torrance man sues over Dorner police shooting
- Vehicle slams into tree, erupts in flames
- Cash in paper bag stolen in Altadena robbery
- Zuma Beach bus line launched from Thousand Oaks
- 1,500 evacuated in wildfire near Yosemite
- 7-Eleven stores exploited immigrants - feds
- abcnews: NFL star's home searched after killing 20 min ago
- Zimmerman attorneys pick 40 potential jurors
- Dave Chappelle to headline Funny or Die tour
- OTRC: Lil Wayne talks on American flag controversy 49 min ago